Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd. (RGNT) Stock Overview

Explore Regentis Biomaterials Ltd.’s financial performance, market position, analyst ratings, and future outlook.

RGNT●AMEX
HealthcareMedical - Instruments & Supplies
$1.96
$0.01(0.51%)
U.S. Market opens in 14h 27m

Regentis Biomaterials Ltd. (RGNT)

Meyka AI Score

Z

Key Financials

Market Cap7.8M
P/E RatioN/A
EPS (TTM)$-24.16
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$2.30
3 Months$1.13
1 Year Target$0.00

RGNT Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Regentis Biomaterials Ltd. (AMEX: RGNT) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Regentis Biomaterials Ltd.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RGNT on the AMEX shows an RSI of 39.46, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.

Key metrics behind Regentis Biomaterials Ltd.'s AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 7.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RGNT on the AMEX.

Price Performance (AMEX: RGNT)

1-Day Change
1.03%
5-Day Change
-11.26%
1-Month Change
-53.10%
3-Month Change
-36.25%
6-Month Change
-71.37%
Year-to-Date (YTD) Change
-70.77%
1-Year Change
-73.73%
3-Year Change
-73.73%
5-Year Change
-73.73%
All-Time (Max) Change
-73.73%

Contact Information

https://www.regentis.co.il
972 9 960 1917
60 Medinat Hayehudim Street, Herzliya, TA, 4676652

Company Facts

100 Employees
IPO DateDec 4, 2025
CountryIL
Actively Trading

Frequently Asked Questions